Nektar Therapeutics · NASDAQ:NKTR

BVF PARTNERS L P/IL reported a 7.40% stake in Nektar Therapeutics (Schedule 13G)

Event Jul 1, 2025 · Filed Jul 9, 2025

BVF PARTNERS L P/IL reported a 7.40% stake in Nektar Therapeutics, 1,276,595 shares, as a passive investor on Jul 1, 2025. Filed Jul 9, 2025 (Schedule 13G).

Stake: 7.40%
Shares: 1,276,595
Intent: Passive
What changed: Crossed above 5%
Filed together: 10 holders

The filing in full

Holder	Stake	Shares
BIOTECHNOLOGY VALUE FUND L P	3.80%	661,758
BVF I GP LLC	3.80%	661,758
BIOTECHNOLOGY VALUE FUND II LP	3.00%	517,813
BVF II GP LLC	3.00%	517,813
Biotechnology Value Trading Fund OS LP	0.40%	71,367
BVF Partners OS Ltd.	0.40%	71,367
BVF GP HOLDINGS LLC	6.80%	1,179,571
BVF PARTNERS L P/IL	7.40%	1,276,595
BVF INC/IL	7.40%	1,276,595
LAMPERT MARK N	7.40%	1,276,595

Source

View original at SEC

Related